Patent · US Active

Process for predicting the prognosis of squamous cell lung cancer

US7927805B2 · kind B2 · utility

5Cited by

0References

3Claims

0Family size

Assignee

Veridex LLC · US

Inventors

Mitch Raponi · San Diego, US
Lesley Estelle Dossey · Escondido, US

Key dates

Filing date	Oct 30, 2008
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Feb 7, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed in this specification is a method for predicting the prognosis of squamous cell lung cancer by observing regulatory changes in select miRNA sequences. These sequences may include hsa-mir-146b, hsa-mir-191, hsa-mir-206, hsa-mir-299-3p, hsa-mir-155, hsa-mir-15a, hsa-mir-122a, hsa-mir-513, hsa-mir-184, hsa-mir-511, hsa-mir-100, hsa-mir-10a, hsa-mir-453, hsa-mir-379, hsa-mir-202, hsa-mir-21, hsa-mir-126, hsa-mir-494, hsa-mir-432, hsa-mir-370, and combinations of these sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.